Kaplan-Meier analysis disclosed significant differences in overall and tumor specific 5-year survival for patients with higher and lower than average cytoplasmic CAV1 expression levels, i.e. 51.4% vs. 75.2% for overall survival and 55.3% vs. 80.1% for disease specific survival, respectively. This evidence concerns the gene CAV1 and neoplasm.